December 5, 2024
By Greg Richter

Compared to users of other hormonal IUDs, those who chose Skyla® showed the lowest risk of developing rosacea one-year, three years and five years after placement, according to new data from researchers at Drexel University College of Medicine, recently published in the Journal of the American Academy of Dermatology.

Read more at Drexel News Blog.

The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.

The images being used are for illustrative purposes only; any person depicted is a model.

 
 Back to Top